Table 5.
F/U biopsy diagnoses in women hrHPV+ with NILM cytology
| Histologic diagnosis | hrHPV genotype | ||||
|---|---|---|---|---|---|
| 16+ | 18/45+ | Other+ | 16+, 18/45+ | Total | |
| Benign | 540 (15.6%) | 334 (9.7%) | 2572 (74.4%) | 11 (0.3%) | 3457 |
| CIN1 | 355 (18.2%) | 193 (9.9%) | 1384 (71.1%) | 14 (0.7%) | 1946 |
| CIN2 | 87 (4.4%) | 22 (1.1%) | 113 (5.8%) | 2 (0.1%) | 224 |
| CIN3 | 121 (56.5%) | 15 (7.0%) | 75 (35.0%) | 3 (1.4%) | 214 |
| SCC | 8 (80.0%) | 1 (10.0%) | 1 (10.0%) | 0 (0.0%) | 10 |
| Total | 1111 (19.0%) | 565 (9.7%) | 4145 (70.8%) | 30 (0.5%) | 5851 |
Abbreviations: CIN1: cervical intraepithelial neoplasia Grade 1; CIN2: cervical intraepithelial neoplasia Grade 2; CIN3: cervical intraepithelial neoplasia Grade 3; SCC, squamous cell carcinoma; hrHPV+, high-risk human papillomavirus positivity.